126 related articles for article (PubMed ID: 31757738)
1. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival.
Eichenauer T; Bannenberg DC; Kluth M; Wittmer C; Büscheck F; Möller K; Dum D; Fraune C; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz TS
Urol Oncol; 2020 Feb; 38(2):43.e13-43.e20. PubMed ID: 31757738
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Eichenauer T; Shadanpour N; Kluth M; Göbel C; Weidemann S; Fraune C; Büscheck F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Burandt E; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz T
World J Surg Oncol; 2020 Jun; 18(1):128. PubMed ID: 32534597
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
Eichenauer T; Simmendinger L; Kluth M; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Büscheck F; Bernreuther C; Clauditz T; Lebok P; Simon R; Sauter G; Wilczak W; Fraune C
Urol Oncol; 2020 Jun; 38(6):605.e1-605.e8. PubMed ID: 32241691
[TBL] [Abstract][Full Text] [Related]
4. 8p deletion is strongly linked to poor prognosis in breast cancer.
Lebok P; Mittenzwei A; Kluth M; Özden C; Taskin B; Hussein K; Möller K; Hartmann A; Lebeau A; Witzel I; Mahner S; Wölber L; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von der Assen A; Müller V; Burandt E
Cancer Biol Ther; 2015; 16(7):1080-7. PubMed ID: 25961141
[TBL] [Abstract][Full Text] [Related]
5. Deletion of 8p is an independent prognostic parameter in prostate cancer.
Kluth M; Amschler NN; Galal R; Möller-Koop C; Barrow P; Tsourlakis MC; Jacobsen F; Hinsch A; Wittmer C; Steurer S; Krech T; Büscheck F; Clauditz TS; Beyer B; Wilczak W; Graefen M; Huland H; Minner S; Schlomm T; Sauter G; Simon R
Oncotarget; 2017 Jan; 8(1):379-392. PubMed ID: 27880722
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
[TBL] [Abstract][Full Text] [Related]
7. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma.
Yamaguchi S; Yoshihiro S; Matsuyama H; Nagao K; Fukunaga K; Matsumoto H; Matsuda K; Oba K; Naito K
Clin Genet; 2003 Mar; 63(3):184-91. PubMed ID: 12694227
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
Moch H; Schraml P; Bubendorf L; Richter J; Gasser TC; Mihatsch MJ; Sauter G
Cancer Res; 1998 Jun; 58(11):2304-9. PubMed ID: 9622063
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
[TBL] [Abstract][Full Text] [Related]
12. A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
Büscheck F; Fraune C; Kluth M; Lennartz M; Simon R; Hube-Magg C; Morlock C; Barbieri S; Wahl C; Eichelberg C; Möller-Koop C; Höflmayer D; Wittmer C; Wilczak W; Sauter G; Fisch M; Eichenauer T; Rink M
World J Urol; 2021 Mar; 39(3):829-837. PubMed ID: 32361874
[TBL] [Abstract][Full Text] [Related]
13. Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.
Stoehr R; Wissmann C; Suzuki H; Knuechel R; Krieg RC; Klopocki E; Dahl E; Wild P; Blaszyk H; Sauter G; Simon R; Schmitt R; Zaak D; Hofstaedter F; Rosenthal A; Baylin SB; Pilarsky C; Hartmann A
Lab Invest; 2004 Apr; 84(4):465-78. PubMed ID: 14968126
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
[TBL] [Abstract][Full Text] [Related]
15. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer.
Oba K; Matsuyama H; Yoshihiro S; Kishi F; Takahashi M; Tsukamoto M; Kinjo M; Sagiyama K; Naito K
Cancer Genet Cytogenet; 2001 Jan; 124(1):20-6. PubMed ID: 11165318
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney.
Schoenberg M; Cairns P; Brooks JD; Marshall FF; Epstein JI; Isaacs WB; Sidransky D
Genes Chromosomes Cancer; 1995 Jan; 12(1):76-80. PubMed ID: 7534117
[TBL] [Abstract][Full Text] [Related]
20. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
